Search
Trinity Biotech PLC
TRIBAdd to Watchlist
6.040USD
-0.710-10.52%
Close 10-08 16:00（ET）
4.91MMarket Cap
LossP/E TTM
Trinity Biotech PLC (TRIB) Revenue Performance
Updated: Dec 31, 2025Last year, Trinity Biotech PLC generated 31.68M USD for its biggest-performing segment, Clinical Laboratory. The Americas made the largest contribution, accounting for 32.39M USD last year.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
Clinical Laboratory
Point of care
Laboratory services
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Clinical Laboratory
31.68M(72.35%)
39.37M(63.96%)
42.29M(74.41%)
46.04M(73.63%)
62.88M(77.49%)
84.28M(82.64%)
68.13M(75.33%)
71.62M(73.81%)
73.37M(74.00%)
74.17M(74.46%)
73.58M(73.43%)
84.84M(80.89%)
71.46M(78.34%)
63.36M(76.79%)
61.39M(78.75%)
Point of care
8.10M(18.50%)
17.43M(28.32%)
9.09M(16.00%)
9.21M(14.74%)
10.34M(12.74%)
9.21M(9.04%)
11.39M(12.60%)
14.84M(15.29%)
16.77M(16.92%)
16.91M(16.97%)
18.81M(18.77%)
20.04M(19.11%)
19.75M(21.66%)
19.15M(23.21%)
16.56M(21.25%)
Laboratory services
4.01M(9.15%)
4.75M(7.72%)
5.45M(9.59%)
7.27M(11.63%)
7.93M(9.77%)
8.48M(8.32%)
10.91M(12.07%)
10.58M(10.90%)
9.00M(9.08%)
8.54M(8.57%)
7.81M(7.79%)
--(--)
--(--)
--(--)
--(--)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
Americas
Ireland
Eliminations
Other Foreign
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Americas
32.39M(73.98%)
41.79M(67.89%)
44.98M(79.15%)
50.51M(80.79%)
67.25M(82.87%)
77.69M(76.18%)
64.05M(70.82%)
65.86M(67.88%)
66.09M(66.67%)
63.89M(64.14%)
60.43M(60.31%)
61.61M(58.75%)
48.68M(53.37%)
42.03M(50.94%)
40.23M(51.61%)
Ireland
11.39M(26.02%)
19.76M(32.11%)
11.85M(20.85%)
12.01M(19.21%)
13.90M(17.13%)
24.29M(23.82%)
26.39M(29.18%)
31.17M(32.12%)
33.05M(33.33%)
35.72M(35.86%)
38.52M(38.45%)
40.98M(39.07%)
40.62M(44.53%)
40.48M(49.06%)
37.72M(48.39%)
Eliminations
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
Other Foreign
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
4.00K(--)
1.24M(1.24%)
2.29M(2.18%)
1.92M(2.11%)
--(--)
--(--)